Article
Author(s):
OKYO Pharma releases positive long-term stability data for urcosimod in neuropathic corneal pain
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Study: No significant long-term benefits found in cocoa extract for AMD
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Pantheon Vision and Eyedeal Medical enter collaborative agreement to develop bioengineered corneal implant
Bausch + Lomb voluntarily recalls select enVista IOLs